Skip to main content
. 2019 Jan 24;9:716. doi: 10.1038/s41598-018-36902-2

Figure 7.

Figure 7

Effect of LOC105375913 overexpression on tubulointerstitial fibrosis in mice. (a) PCR analysis of LOC105375913 in tubulointerstitial tissues of mice treated with control plasmid or LOC105375913-expressing plasmid; (b) ISH analysis of LOC105375913 in tubulointerstitial tissues of mice (n = 6); (c) Masson staining of renal sections in mice (n = 6); (d) Level of serum creatinine in mice (n = 6); (e) Level of pri-miR-27b and miR-27b in tubulointerstitial tissues of mice (n = 6); (f) RNA pull-down and RT-PCR analysis of the binding between LOC105375913 and miR-27b in tubulointerstitial tissues of mice (n = 6); (g) Western blot analysis of snail in tubulointerstitial tissues of mice (n = 6); (h) RT-PCR analysis of FN and Col I in tubulointerstitial tissues of mice (n = 6); (i) Western blot analysis of FN and Col I in tubulointerstitial tissues of mice (n = 6). For statistical analysis, a two-tailed Student’s t-test was used for (d,e and h), and one-way ANOVA with Tukey’s post hoc test was used for (f). *P < 0.05 compared with mice treated with control plasmid. Bar = 20 μm.